Leveraging our deep understanding of established antibody drug targets and our
advanced in-house chemical process platform, Abinvivo has developed a robust pipeline
of biologics.
By utilizing investigational drug targets as blueprints, we provide tailored custom
synthesis services for a diverse array of benchmark positive antibodies. Our offerings
encompass a broad spectrum of critical targets, including PD-1, CTLA4, HER2, 4-iBB, and
many more, to support your antibody drug research endeavors.
More Information >